We strongly thank the other members of BILHVAX Clinical trial team:
From the BRC EPLS: S.K. Guindo; G. Sam; L. Bandany; I. Diakhaté; J. Bahépar; A.D. Diop; M. Diop; C.S. Sow; S. Sow; Z. Diamé; R. Diagne-Koné; C. Thiam; I. Talla; I. Dramé; J-L. Martegoute; L. Saumet; F. Rogerie; L. Gaayeb; A. Fressancourt; M. Cassin; S. Boutouaba-Combé; A.J. Brigaud.
From Eurogentec: C. Schaus; E.M. McNamara; A. Hoyoux.
From the CIC 1403: C. Libersa; C. Cunisse; P. Gelé; S. Vermoesen; A. Topart; P. Bechu; T. Ouk; B. Accard.
From the Inserm SC10-US019, Villejuif, (France): J-P. Aboulker; I. Charreau; C. Capitant; Y. Saïdi.
From PRC Inserm: C. Sébastiani; C. Gaultier; G. Dagher; H. Pollard.
From WHO Special Programme for Research and Training in Tropical Diseases: M-P. Kieny; V. Mazarin-Diop.
Members of Scientific Commitee: M. Tanner (chairman); D. Dunne; B. Vennervald; J. Richter; B. Sambou.
DSMB members: B. Sambou (Chairman); H. Dieng; A. Dieye; H. P. Ndiaye; R. C. Tine; J. Bénichou; X. Anglaret; S. Blanche.
"We are strongly grateful to I. Talla, J-F. Delfraissy; G. Bréart; M. Diop; P. Dalimier; C. Mazingue; G. Sevrin; S. Cor Sarr."
We warmly thank the populations of the 13 selected villages and the district physician chiefs and chief nurses for their close collaboration, without which this study could not have been done.